Company Filing History:
Years Active: 2025
Title: Sam Sinai: Innovator in Gene Delivery Technology
Introduction
Sam Sinai is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of gene delivery technology. His work focuses on improving the efficiency of viral vectors used in gene therapy.
Latest Patents
Sam Sinai holds a patent for "Viral vectors exhibiting improved gene delivery properties." This technology provides viral capsid polypeptides that bear mutations, altering the tissue tropism of a virus. In various embodiments, the tissue tropism can be directed to the heart, kidney, liver, lung, spleen, or blood, enhancing the potential for targeted gene therapy.
Career Highlights
Sam Sinai is affiliated with Harvard College, where he conducts his research and development. His work has positioned him as a key figure in the advancement of gene delivery systems.
Collaborations
He has collaborated with prominent scientists in the field, including George M. Church and Eric Kelsic. These collaborations have further enriched his research and contributed to the development of innovative solutions in gene therapy.
Conclusion
Sam Sinai's contributions to gene delivery technology exemplify the impact of innovative thinking in the field of biotechnology. His work continues to pave the way for advancements in gene therapy applications.